Melbourne-based Atomos (ASX:AMS) announced a binding agreement to acquire Flanders Scientific.
The acquisition is designed to integrate FSI’s world-renowned professional reference monitors into the Atomos ecosystem, creating a comprehensive end-to-end workflow solution that spans from on-camera recording to final delivery.
The financial structure of the deal includes an upfront consideration of $2.4 million in cash, supplemented by the issuance of over 5.6 million AMS shares.
Furthermore, the agreement incorporates a performance-based earn-out provision, contingent upon the achievement of specific milestones.
Atomos intends to fund the purchase through its recently announced CBA Finance Facility, ensuring that FSI remains debt-free upon completion of the merger.
FSI brings a robust financial track record to the table, having averaged an annual revenue of $11 million with an EBITDA of $0.45 million over the last five years.
In 2025, FSI saw revenues climb to $12.7 million. Atomos anticipates significant operational advantages from this union, projecting a post-synergy annual EBITDA of $1 million for the FSI segment, even before accounting for future revenue growth.
Peter Barber, Managing Director and CEO of Atomos, emphasised the cultural and technical alignment between the two brands, noting that FSI’s reputation for excellence and trust directly supports the broader vision for Atomos’ expansion.